Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers
- 12 March 2004
- Vol. 22 (9-10) , 1087-1096
- https://doi.org/10.1016/j.vaccine.2003.10.005
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Neisseria meningitidisserogroup B: laboratory correlates of protectionFEMS Immunology & Medical Microbiology, 2002
- Activity and Cross-Reactivity of Antibodies Induced in Mice by Immunization with a Group B Meningococcal ConjugateInfection and Immunity, 2001
- Preclinical Evaluation of a Novel Group B Meningococcal Conjugate Vaccine that Elicits Bactericidal Activity in both Mice and Nonhuman PrimatesThe Journal of Infectious Diseases, 1997
- Epidemiology and prevention of meningococcal diseaseThe Pediatric Infectious Disease Journal, 1995
- Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteinsVaccine, 1991
- Serotype-specific outbreak of group B meningococcal disease in Iquique, ChileEpidemiology and Infection, 1990
- Embryonic neural cell adhesion molecules on human natural killer cellsEuropean Journal of Immunology, 1989
- An integrated molecular and immunological approach towards a meningococcal group B vaccineVaccine, 1987
- A monoclonal antibody against meningococcus group B polysaccharides distinguishes embryonic from adult N-CAM.The Journal of cell biology, 1986
- Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in ManJournal of Clinical Investigation, 1979